NDAORALSUSPENSION, EXTENDED RELEASE
Approved
Mar 2013
Lifecycle
Peak
Competitive Pressure
8/100
Mechanism of Action
12.1 Mechanism of Action Carbinoxamine is an H1 receptor antagonist (antihistamine) that exhibits anticholinergic (drying) and sedative properties. Antihistamines compete with histamine for receptor sites on effector cells. 12.3 Pharmacokinetics Carbinoxamine Maleate extended-release oral…
Loss of Exclusivity
LOE Date
Mar 29, 2029
37 months away
Patent Expiry
Mar 29, 2029
Company
Aytu BioPharma
DENVER, CO